OUR SCIENCE
Targeted protein degradation
Our degraders are designed to eliminate disease-causing proteins by harnessing the cell’s natural protein degradation machinery.
Our DACs combine the cell specificity of antibodies with the potency, selectivity, and catalytic activity of degraders, delivering innovative medicines with the potential for enhanced precision and improved safety.
Our innovative and prolific DEL-AI drug discovery engine is powering the protein degradation revolution.
We are translating the science of degradation into clinical progress, advancing a multi-modal pipeline that targets a broad range of cancers and autoimmune diseases.
OUR MISSION
Establishing degrader-based medicines at the forefront of patient care
We are steadfast in our pursuit to provide patients with safer, deeper, more durable responses for sustained disease control.
OUR CULTURE
Surpass what is possible
We believe in the transformative power of targeted protein degradation to unlock a new universe of treatment options for patients. Join us in writing medicine’s next chapter.
OUR FOCUS